Tecnologia aplicada na detecção de marcadores tumorais
Conteúdo do artigo principal
Resumo
Downloads
Detalhes do artigo
Referências
Sklar JL, Costa JC. Principles of cancer management: molecular pathology. In: DeVita VT et al (editors). Cancer: principles and practice of oncology. 5th ed. Philadelphia: Lippincott-Raven: 1997, p. 259.
Yamaguchi K et al. Polymerase chain reaction-based approaches for detection of allelic loss in the p53 tumor suppressor gene in colon neoplasms. Am J Gastroenterol 1997;92:307-12.
Chang C, Meyerowitz EM. Plant genome studies: restriction fragment length polymorphism and chromosome mapping information. Curr Opin Genet Dev 1991;1:112-8. http://dx.doi.org/10.1016/0959-437X(91)80051-M
Alwine JC, Kemp DJ, Stark GR. Method for detection of specific RNAs in agarose gels by transfer to diabenzyloxymethyl-paper and hibridization with DNA probes. Proc Natl Acad Sci USA 1977;74:5350-4. http://dx.doi.org/10.1073/pnas.74.12.5350
Berk AJ, Sharp PA. Sizing and mapping of early adenovirus mRNA by gel electrophoresis of S1 endonuclear digesated hybrids. Cell 1977;12:721-32. http://dx.doi.org/10.1016/0092-8674(77)90272-0
Grunstein M, Hogness DS. Colony hybydization: a method for the isolation of cloned DNAs that contain a specifc gene. Proc Natl Acad Sci. USA 1975;72: 3961-5. http://dx.doi.org/10.1073/pnas.72.10.3961
Lathe R. Synthetic oligonucleotide probes deduced from amino acid sequence data. Theoretical and practical considerations. J Mol Biol 1985;183:1-12. http://dx.doi.org/10.1016/0022-2836(85)90276-1
Trask BJ. Gene mapping by in situ hybridization. Curr Opin Genet Dev 1991;1:82-7. http://dx.doi.org/10.1016/0959-437X(91)80046-O
Koshinen PJ, Alitalo K. Role of myc amplification and overexpression in cell growth, differentiation, and death. Semin Cancer Biol 1993;4:3.
Broone S, Gilbert W. Immunological screening method to detect specific translation products. Proc Natl Acad Sci USA 1978;75:2746-9. http://dx.doi.org/10.1073/pnas.75.6.2746
Harlow E, Lane D. Using antibioties: a laboratory manual. Cold Spring Harbor, Nova York: Cold Spring Laboratory Presss: 1999.
Cotran RS, Kumar V, Collins T. Robbins. Patologia estrutural e funcional. 6a ed. Philadelphia: Editora Guanabara Koogan: 2000.
Pamies RJ, Crawford DR. Tumor markers: DNA update. Med Clin North Am 1996;80:185. http://dx.doi.org/10.1016/S0025-7125(05)70435-1
Hayes DF, Bast RC et al. Tumor marker utility grading system: A framework to evaluate clinical utility of tumor markers. J Nat Cancer Inst 1996;88:1456-66. http://dx.doi.org/10.1093/jnci/88.20.1456
Baynes J, Dominiczac MH. Bioquímica médica. 1a ed. São Paulo: Editora Manole: 2000.
ASCO (American Society of Clinical Oncology). 1997 update of recommendations for the use of tumor markers in breast and colorectal cancer. J Clin Oncol 1998; 16:793-5.
ASCO (American Society of Clinical Oncology). Clinical practice guidelines for the use of tumor markers in breast and colorectal cancer. J Clin Oncol 1994;10:2843-77.
Canevari S, Pupa SM et al. 1975-1995 Revised anti-cancer serological response: biological significance and clinical implications. Ann Oncol 1997;7:227-32. http://dx.doi.org/10.1093/oxfordjournals.annonc.a010564
Von Kleist S. Molecular biology of the carcinoembryonic antigen. In: Ballesta A, Torre GC et al. Up dating on tumor markers in tissue and in biological fluids. Minerva Medica, Torino: 1997.
Veronesi U, Luini A, Costa A, Andreoli C. Mastologia oncológica. 1a ed. Milão: Editora Medsi: 2002.
Lin S-CJ. Gene in the Rb pathway and their knockout in mice. Semin Cancer Biol 1996;7:279. http://dx.doi.org/10.1006/scbi.1996.0036
Gusterson BA, Gelber RD et al. Prognostic importance of c-erbB-2 expression in breast cancer. J Clin Oncol 1992;10:1049-56.
Salomon DS et al. Epidermal growth factor-related peptides and their receptors in human malignancies. Crit Ver Hematol Oncol 1995;19:183. http://dx.doi.org/10.1016/1040-8428(94)00144-I
Muss HB, Thor A et al. c-erbB-2 expression and S-phase activity predict response to adjuvant therapy in women with node-positive early breast cancer. N Engl J Med 1994;330:1260-6. http://dx.doi.org/10.1056/NEJM199405053301802
deVaries JE et al. p21ras in carcinogenesis. Pathol Res Pract 1996;192:658. http://dx.doi.org/10.1016/S0344-0338(96)80087-2
Waldmann V, Robes HM. What's new in Ras genes? Pathol Res Pract 1996;192:883. http://dx.doi.org/10.1016/S0344-0338(96)80067-7
Leone G et al. Myc and Ras collaborate in inducing accumulation of active cyclin E/cdk2 and E2F. Nature 1997;387:422. http://dx.doi.org/10.1038/387422a0
Baringa M. News. From benchtop to bedside. Science 1997;278:1036. http://dx.doi.org/10.1126/science.278.5340.1036
Sanchez-Garcia I, Martin-Zonca D. Regulation of bcl-2 gene expression by bcr-c-abl is mediated by ras. J Mol Biol 1997;267:225. http://dx.doi.org/10.1006/jmbi.1996.0779
Levine AJ. p53, the cellular gatekeeper for growth and division. Cell 1997;88:323. http://dx.doi.org/10.1016/S0092-8674(00)81871-1
Graeber AJ et al. Hypoxia-mediated selection of cells with diminished apoptotic potencial in solid tumors. Nature 1996;379:88. http://dx.doi.org/10.1038/379088a0
Scherr CJ. Cancer cell cycle. Science 1996;274:1672. http://dx.doi.org/10.1126/science.274.5293.1672
Oren M. Lonely no more: p53 finds its kin in a tumorsuppressor haven. Cell 1997;90:829. http://dx.doi.org/10.1016/S0092-8674(00)80347-5
Somasundaram K et al. Arrest of the cell cycle by the tumor-spupressor BRCA-1 requires the CDK inhibitor p21WAF-1/CiP1. Nature 1997;389:187. http://dx.doi.org/10.1038/38291